IP Library › Assignment 057531/0556
Patent Assignment
Reel/Frame 057531/0556

Release of Security Interest

Recorded: 2021-09-20 Pages: 12
Assignor
Assignee
SILVERGATE PHARMACEUTICALS, INC.
8 CABOT ROAD, SUITE 2000, WOBURN, MASSACHUSETTS, 01801
Covered Properties (23)
Enalapril Compositions
Patent: 8,568,747 →
Application: 13/670,355 →
Enalapril Compositions
Patent: 8,778,366 →
Application: 13/914,452 →
Publication: US 2014/0100260
Lisinopril Formulations
Patent: 9,463,183 →
Application: 14/934,752 →
Enalapril Formulations
Patent: 9,669,008 →
Application: 15/081,603 →
Lisinopril Formulations
Patent: 9,616,096 →
Application: 15/268,095 →
Publication: US 2017/0119840
Enalapril Compositions
Patent: 9,855,214 →
Application: 15/433,743 →
Publication: US 2017/0181968
Lisinopril Formulations
Patent: 9,814,751 →
Application: 15/483,691 →
Publication: US 2017/0209523
Enalapril Formulations
Patent: 9,808,442 →
Application: 15/613,622 →
Publication: US 2017/0266159
Enalapril Formulations
Application: 15/802,341 →
Publication: US 2018/0055821
Lisinopril Formulations
Application: 15/805,934 →
Publication: US 2018/0078604
Enalapril Compositions
Patent: 9,968,553 →
Application: 15/850,732 →
Publication: US 2018/0116954
Enalapril Formulations
Application: 16/003,994 →
Publication: US 2018/0289669
Lisinopril Formulations
Application: 16/053,164 →
Publication: US 2018/0339011
Enalapril Formulations
Application: 16/177,159 →
Publication: US 2019/0070147
Enalapril Formulations
Application: 16/242,898 →
Publication: US 2019/0142797
Lisinopril Formulations
Application: 16/295,482 →
Publication: US 2019/0201475
Lisinopril Formulations
Application: 16/564,904 →
Publication: US 2020/0206298
Lisinopril Formulations
Application: 16/822,412 →
Publication: US 2020/0237851
Enalapril Formulations
Application: 16/883,553 →
Publication: US 2020/0281893
Enalapril Formulations
Application: 16/991,575 →
Publication: US 2020/0368200
Enalapril Formulations
Application: 17/150,587 →
Publication: US 2021/0137882
Lisinopril Formulations
Application: 17/194,021 →
Publication: US 2021/0187055
Enalapril Formulations
Application: 17/228,024 →
Publication: US 2021/0251956
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest Nov 3, 2015
From: SILVERGATE PHARMACEUTICALS, INC.
To: ESCALATE CAPITAL PARTNERS SBIC III, LP
Reel/Frame 036945/0861 →
Assignment of Assignor's Interest Nov 6, 2015
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 037066/0263 →
Security Interest Nov 23, 2015
From: SILVERGATE PHARMACEUTICALS, INC.
To: COMERICA BANK
Reel/Frame 037123/0437 →
Assignment of Assignor's Interest Apr 8, 2016
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 038792/0116 →
Assignment of Assignor's Interest Sep 16, 2016
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 040066/0323 →
Assignment of Assignor's Interest Feb 16, 2017
From: BECKLOFF, MICHAEL C.; SEGRAVE, FRANK; MAURO, ROBERT; COLABUONO, PETER
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 041278/0264 →
Assignment of Assignor's Interest Feb 16, 2017
From: RAJEWSKI, LIAN G.; RAJEWSKI, ROGER A.; HASLAM, JOHN L.; HEPPERT, KATHLEEN
To: UNIVERSITY OF KANSAS
Reel/Frame 041278/0887 →
Assignment of Assignor's Interest Apr 19, 2017
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 042097/0015 →
Assignment of Assignor's Interest Jun 13, 2017
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 042786/0848 →
Assignment of Assignor's Interest Nov 10, 2017
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 044090/0445 →
Assignment of Assignor's Interest Nov 10, 2017
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 044090/0243 →
Release of Security Interest Dec 28, 2017
From: ESCALATE CAPITAL PARTNERS SBIC III, LP
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 044498/0193 →
Assignment of Assignor's Interest Dec 29, 2017
From: RAJEWSKI, LIAN G.; RAJEWSKI, ROGER A.; HASLAM, JOHN L.; HEPPERT, KATHLEEN
To: UNIVERSITY OF KANSAS
Reel/Frame 044508/0056 →
Assignment of Assignor's Interest Dec 29, 2017
From: BECKLOFF, MICHAEL C.; SEGRAVE, FRANK; MAURO, ROBERT; COLABUONO, PETER
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 044507/0962 →
Assignment of Assignor's Interest Jun 8, 2018
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 046340/0863 →
Assignment of Assignor's Interest Sep 5, 2018
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 047479/0828 →
Assignment of Assignor's Interest Oct 31, 2018
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 047902/0121 →
Release of Security Interest Dec 12, 2018
From: COMERICA BANK
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 047753/0401 →
Release of Security Interest Dec 12, 2018
From: COMERICA BANK
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 047753/0443 →
Security Interest Dec 19, 2018
From: ARGENTUM HOLDINGS, LLC; SILVERGATE PHARMACEUTICALS, INC.
To: WHITE OAK HEALTHCARE FINANCE, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 047815/0615 →
Assignment of Assignor's Interest Jan 9, 2019
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 048040/0659 →
Assignment of Assignor's Interest Mar 7, 2019
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 048536/0610 →
Release of Security Interest May 17, 2019
From: WHITE OAK HEALTHCARE FINANCE, LLC, AS AGENT
To: ARGENTUM HOLDINGS, LLC; SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 049211/0188 →
Security Interest May 17, 2019
From: CUTISPHARMA, INC.; SILVERGATE PHARMACEUTICALS, INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 049209/0272 →
Assignment of Assignor's Interest Sep 9, 2019
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 050320/0949 →